Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AST-120”

20 trials

Showing 20 of 20 results

Post-approval studies (Phase 4)Study completedNCT01681303
What this trial is testing

Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.

Who this might be right for
Chronic Kidney DiseaseAST-120
Chang Gung Memorial Hospital 51
Large-scale testing (Phase 3)Study completedNCT00500682
What this trial is testing

AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Who this might be right for
Chronic Kidney Disease
Tanabe Pharma Corporation 1,020
Large-scale testing (Phase 3)Study completedNCT00501046
What this trial is testing

AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

Who this might be right for
Chronic Kidney Disease
Tanabe Pharma Corporation 1,015
Large-scale testing (Phase 3)Study completedNCT00321412
What this trial is testing

Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas

Who this might be right for
Inflammatory Bowel DiseaseIntestinal Fistula
Ocera Therapeutics 191
Post-approval studies (Phase 4)Study completedNCT00860431
What this trial is testing

Kremezin Study Against Renal Disease Progression in Korea

Who this might be right for
Chronic Kidney Disease
Seoul National University Hospital 578
Testing effectiveness (Phase 2)Study completedNCT00867698
What this trial is testing

AST-120 Used to Treat Mild Hepatic Encephalopathy

Who this might be right for
Mild Hepatic Encephalopathy
Ocera Therapeutics 148
Testing effectiveness (Phase 2)Study completedNCT00583128
What this trial is testing

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Ocera Therapeutics 117
Early research (Phase 1)Study completedNCT02693613
What this trial is testing

Pharmacokinetic Study of ASP1517 With Kremezin®

Who this might be right for
Healthy Volunteers
Astellas Pharma Inc 34
Post-approval studies (Phase 4)Looking for participantsNCT07182422
What this trial is testing

AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease

Who this might be right for
Acute Kidney DiseaseAcute Kidney Injury (AKI)
Chang Gung Memorial Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00583076
What this trial is testing

Safety and Efficacy of AST-120 in the Treatment of Pouchitis

Who this might be right for
Pouchitis
Ocera Therapeutics 19
Post-approval studies (Phase 4)Study completedNCT02681952
What this trial is testing

A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure

Who this might be right for
Chronic Renal Failure
Daewon Pharmaceutical Co., Ltd. 153
Post-approval studies (Phase 4)Study completedNCT04639674
What this trial is testing

AST-120 in Hemodialysis Patients With Uremic Pruritus

Who this might be right for
Uremic Pruritus
Conmed Pharmaceutical & Bio-Medical Corporation 100
Testing effectiveness (Phase 2)Ended earlyNCT00587275
What this trial is testing

Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Ocera Therapeutics 4
Early research (Phase 1)Study completedNCT00719758
What this trial is testing

Drug-Drug Interaction Study of TRK-100STP

Who this might be right for
Healthy
Astellas Pharma Inc 24
Post-approval studies (Phase 4)UnknownNCT01157260
What this trial is testing

The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease

Who this might be right for
Kidney Failure, Chronic
Ewha Womans University 30
Large-scale testing (Phase 3)UnknownNCT02687841
What this trial is testing

A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury

Who this might be right for
Acute Kidney Injury
National Taiwan University Hospital 206
Testing effectiveness (Phase 2)Ended earlyNCT00583531
What this trial is testing

Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis

Who this might be right for
Pouchitis
Ocera Therapeutics 2
Testing effectiveness (Phase 2)Study completedNCT00558038
What this trial is testing

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Ocera Therapeutics 40
Post-approval studies (Phase 4)Study completedNCT01458652
What this trial is testing

Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation

Who this might be right for
Loss of Solute Clearance
Tungs' Taichung Metroharbour Hospital 30
Post-approval studies (Phase 4)Study completedNCT03788252
What this trial is testing

Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Gumi Cha Medical Center 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation